首页> 美国卫生研究院文献>The Journal of Neuroscience >p38 Mitogen-Activated Protein Kinase Contributes to Adenosine A1 Receptor-Mediated Synaptic Depression in Area CA1 of the Rat Hippocampus
【2h】

p38 Mitogen-Activated Protein Kinase Contributes to Adenosine A1 Receptor-Mediated Synaptic Depression in Area CA1 of the Rat Hippocampus

机译:p38丝裂原激活的蛋白激酶有助于大鼠海马CA1区腺苷A1受体介导的突触抑制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenosine is arguably the most potent and widespread presynaptic modulator in the CNS, yet adenosine receptor signal transduction pathways remain unresolved. Here, we demonstrate a novel mechanism in which adenosine A1 receptor stimulation leads to p38 mitogen-activated protein kinase (MAPK) activation and contributes to the inhibition of synaptic transmission. Western blot analysis indicated that selective A1 receptor activation [with N6-cyclopentyladenosine (CPA)] resulted in rapid increases in phosphorylated p38 (phospho-p38) MAPK immunoreactivity in membrane fractions, and decreases in phospho-p38 MAPK in cytosolic fractions. Immunoprecipitation with a phospho-p38 MAPK antibody revealed constitutive association of this phosphoprotein with adenosine A1 receptors. Phospho-p38 MAPK activation by A1 receptor stimulation induced translocation of PP2a (protein phosphatase 2a) to the membrane. We then examined the actions of p38 MAPK activation in A1 receptor-mediated synaptic inhibition. Excitatory postsynaptic field potentials evoked in area CA1 of the rat hippocampus markedly decreased in response to adenosine (10 μm), the A1 receptor agonist CPA (40 nm), or a 5 min exposure to hypoxia. These inhibitory responses were mediated by A1 receptor activation because the selective antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine) (100 nm) prevented them. In agreement with the biochemical analysis, the selective p38 MAPK inhibitor SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole] (25 μm) blocked the inhibitory actions of A1 receptor activation, whereas both the inactive analog SB202474 [4-ethyl-2-(p-methoxyphenyl)-5-(4′-pyridyl)-1H-imidazole] (25 μm) and the ERK 1/2 (extracellular signal-regulated kinase 1/2) MAPK inhibitor PD98059 [2′-amino-3′-methoxyflavone] (50 μm) were ineffective. In contrast, the p38 MAPK inhibitors did not inhibit GABAB-mediated synaptic depression. These data suggest A1 receptor-mediated p38 MAPK activation is a crucial step underlying the presynaptic inhibitory effect of adenosine on CA3–CA1 synaptic transmission.
机译:腺苷可以说是中枢神经系统中最有效和最广泛的突触前调节剂,但腺苷受体信号转导途径仍未解决。在这里,我们证明了一种新的机制,其中腺苷A1受体刺激导致p38丝裂原激活的蛋白激酶(MAPK)激活,并有助于抑制突触传递。蛋白质印迹分析表明,选择性的A1受体激活[用N 6 -环戊基腺苷(CPA)]可导致膜级分中磷酸化的p38(phospho-p38)MAPK免疫反应性迅速增加,而磷酸化p38则降低胞浆级分中的MAPK。磷酸化p38 MAPK抗体的免疫沉淀显示该磷酸化蛋白与腺苷A1受体组成型相关。通过A1受体刺激激活的磷酸化p38 MAPK诱导了PP2a(蛋白磷酸酶2a)向膜的移位。然后,我们检查了p38 MAPK激活在A1受体介导的突触抑制中的作用。响应腺苷(10μm),A1受体激动剂CPA(40 nm)或缺氧5分钟,在大鼠海马CA1区引起的兴奋性突触后场电位显着降低。这些抑制反应是由A1受体激活介导的,因为选择性拮抗剂DPCPX(8-环戊基-1,3-二丙基黄嘌呤)(100 nm)阻止了它们。与生化分析一致,选择性p38 MAPK抑制剂SB203580 [4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑](25μm)阻断了抑制作用A1受体激活,而无活性的类似物SB202474 [4-乙基-2-(对甲氧基苯基)-5-(4'-吡啶基)-1H-咪唑](25μm)和ERK 1/2(细胞外信号调节激酶1/2)MAPK抑制剂PD98059 [2'-氨基-3'-甲氧基黄酮](50μm)无效。相反,p38 MAPK抑制剂不抑制GABAB介导的突触抑制。这些数据表明,A1受体介导的p38 MAPK激活是腺苷对CA3-CA1突触传递的突触前抑制作用的关键步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号